Stay updated on Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference3%
- Check25 days agoChange DetectedApp page now shows Revision: v3.1.0 and removes several MedlinePlus drug safety topics, reducing related content coverage.SummaryDifference0.4%
- Check39 days agoChange DetectedUpdated to Revision: v3.0.2 (from v3.0.1) and removed the Back to Top element. This appears to be a routine release update with minor UI cleanup.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as a focus on drug safety and counterfeit drugs. The revision number has also been updated to v3.0.0.SummaryDifference2%
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.